Modernizing Perinatal Syphilis Testing
Start Date
5/2/2023
Completion Date
11/30/2027
Summary
The purpose of this study is to determine the testing performance of real-time quantitative polymerase chain reaction and transcription mediated amplification by comparing test performance of these novel molecular tests to current 2021 CDC CS guidelines for maternal/neonatal dyads at risk for syphilis infection and to determine whether CS is associated with adverse neurodevelopmental outcomes.
Eligibility Criteria
Age Range: No minimum to 45 years
Interventions
Quantitative polymerase chain reaction (qPCR) assay for detection of Treponema pallidum
Aptima Treponema pallidum transcription-mediated amplification (TMA) assay for detection of Treponema pallidum
Center for Disease Control (CDC) Sexually Transmitted Infections (STI) 2021 Treatment Guidelines for diagnosis of syphilis
Conditions
Locations
University of Southern California
Los Angeles, California 90007
United States
University of California, Los Angeles
Los Angeles, California 90095
United States
Johns Hopkins University
Baltimore, Maryland 21205
United States
Kennedy Krieger Institute
Baltimore, Maryland 21205
United States
Nationwide Children's Hospital
Columbus, Ohio 43205
United States
Baylor College of Medicine
Houston, Texas 77030
United States
Texas Children's Hospital
Houston, Texas 77030
United States
The University of Texas Health Science Center at Houston
Houston, Texas 77030
United States
Christus Health
Houston, Texas 78130
United States